Shandong Weigao Group Medical Polymer Company Limited (1066.HK)
HKD 5.7
(-0.18%)
HKD 5.7
(-0.18%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.59 Billion CNY | -54.42% |
| 2022 | 3.5 Billion CNY | -0.34% |
| 2021 | 3.51 Billion CNY | -12.49% |
| 2020 | 4.01 Billion CNY | -9.86% |
| 2019 | 4.45 Billion CNY | -12.55% |
| 2018 | 5.09 Billion CNY | 533.23% |
| 2017 | 804.27 Million CNY | 1.58% |
| 2016 | 791.8 Million CNY | 21.97% |
| 2015 | 649.2 Million CNY | 335.41% |
| 2014 | 149.1 Million CNY | 49.55% |
| 2013 | 99.7 Million CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 63 Million CNY | -28.64% |
| 2010 | 88.3 Million CNY | -22.41% |
| 2009 | 113.8 Million CNY | -16.74% |
| 2008 | 136.69 Million CNY | -35.16% |
| 2007 | 210.8 Million CNY | -24.98% |
| 2006 | 281 Million CNY | 33.81% |
| 2005 | 210 Million CNY | 42.08% |
| 2004 | 147.8 Million CNY | -4.62% |
| 2003 | 154.96 Million CNY | 48.16% |
| 2002 | 104.59 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 3.43 Billion CNY | -1.97% |
| 2023 Q4 | 1.59 Billion CNY | 0.0% |
| 2023 FY | 1.59 Billion CNY | -54.42% |
| 2023 Q2 | 3.43 Billion CNY | 0.0% |
| 2023 Q3 | 1.59 Billion CNY | -53.5% |
| 2022 Q2 | 3.54 Billion CNY | 0.0% |
| 2022 Q4 | 3.5 Billion CNY | 0.0% |
| 2022 FY | 3.5 Billion CNY | -0.34% |
| 2022 Q3 | 3.5 Billion CNY | -1.13% |
| 2022 Q1 | 3.54 Billion CNY | 0.8% |
| 2021 Q3 | 3.51 Billion CNY | -2.64% |
| 2021 FY | 3.51 Billion CNY | -12.49% |
| 2021 Q4 | 3.51 Billion CNY | -0.01% |
| 2021 Q2 | 3.6 Billion CNY | 0.0% |
| 2021 Q1 | 3.6 Billion CNY | -10.12% |
| 2020 Q1 | 3.98 Billion CNY | -10.49% |
| 2020 Q2 | 3.98 Billion CNY | 0.0% |
| 2020 Q3 | 4.02 Billion CNY | 0.85% |
| 2020 Q4 | 4.01 Billion CNY | -0.14% |
| 2020 FY | 4.01 Billion CNY | -9.86% |
| 2019 Q4 | 4.45 Billion CNY | 0.0% |
| 2019 FY | 4.45 Billion CNY | -12.55% |
| 2019 Q2 | 4.63 Billion CNY | 0.0% |
| 2019 Q1 | 4.63 Billion CNY | -9.01% |
| 2019 Q3 | 4.45 Billion CNY | -3.89% |
| 2018 FY | 5.09 Billion CNY | 533.23% |
| 2018 Q1 | 4.63 Billion CNY | 476.43% |
| 2018 Q2 | 4.63 Billion CNY | 0.0% |
| 2018 Q3 | 5.09 Billion CNY | 9.85% |
| 2018 Q4 | 5.09 Billion CNY | 0.0% |
| 2017 FY | 804.27 Million CNY | 1.58% |
| 2017 Q4 | 804.27 Million CNY | 0.0% |
| 2017 Q3 | 804.27 Million CNY | -1.1% |
| 2017 Q2 | 813.22 Million CNY | 0.0% |
| 2017 Q1 | 813.22 Million CNY | 2.71% |
| 2016 Q1 | 698 Million CNY | 7.52% |
| 2016 FY | 791.8 Million CNY | 21.97% |
| 2016 Q4 | 791.8 Million CNY | 0.0% |
| 2016 Q3 | 791.8 Million CNY | 13.44% |
| 2016 Q2 | 698 Million CNY | 0.0% |
| 2015 Q1 | 748.9 Million CNY | 402.28% |
| 2015 Q2 | 748.9 Million CNY | 0.0% |
| 2015 Q4 | 649.2 Million CNY | 0.0% |
| 2015 FY | 649.2 Million CNY | 335.41% |
| 2015 Q3 | 649.2 Million CNY | -13.31% |
| 2014 Q4 | 149.1 Million CNY | 0.0% |
| 2014 FY | 149.1 Million CNY | 49.55% |
| 2014 Q2 | 99.6 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 FY | 99.7 Million CNY | 0.0% |
| 2013 Q4 | 99.7 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | - CNY | -100.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2011 FY | 63 Million CNY | -28.64% |
| 2011 Q2 | 75.5 Million CNY | 0.0% |
| 2010 Q2 | 101.86 Million CNY | 0.0% |
| 2010 FY | 88.3 Million CNY | -22.41% |
| 2009 FY | 113.8 Million CNY | -16.74% |
| 2008 FY | 136.69 Million CNY | -35.16% |
| 2007 FY | 210.8 Million CNY | -24.98% |
| 2006 FY | 281 Million CNY | 33.81% |
| 2005 FY | 210 Million CNY | 42.08% |
| 2004 FY | 147.8 Million CNY | -4.62% |
| 2003 FY | 154.96 Million CNY | 48.16% |
| 2002 FY | 104.59 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Kaisa Health Group Holdings Limited | 10.18 Million HKD | -15574.524% |
| Elegance Optical International Holdings Limited | - HKD | -Infinity% |
| Arts Optical International Holdings Limited | 4.98 Million HKD | -31941.357% |
| Kelfred Holdings Limited | 12.47 Million HKD | -12696.504% |
| Modern Dental Group Limited | 612.49 Million HKD | -160.572% |